Tools and materials are needed for pharmacoeconomic evaluation and health technology assessment (HTA) training to strengthen health systems and increase and support their capacity to perform HTA in resource-limited countries. Training on how to apply pharmacoeconomics to essential medicines selection should focus on equipping health care workers, regulatory authorities, public health program personnel, and academic researchers with the skills and knowledge to strengthen pharmacoeconomic decision making as part of HTA within their health systems. This guide provides a template for use, adaptation, or adoption in many settings. It is intended that these materials will be adapted and supplemented to meet the needs and contexts of individual countries. In addition to this trainer’s guide, the curriculum package includes presentation slides, case studies, and other resources. The package is meant to provide resources and information to help trainers and facilitators conduct in-person trainings and develop local capacity for evidence based medical product selection. Included in this curriculum are nine training modules with notes for facilitators and guidance for each module, as well as workgroup activities and case studies to accompany the presentations. In addition to being a guide and basic platform that can be adapted for different settings, this material can serve as the basis for developing delivery formats beyond in-person trainings, such as distance or online training, to meet local stakeholder needs. Resources and materials for further reading are included to help enhance knowledge and prepare facilitators.
Archive | PresentationRSS feed for this section
Applying Principles of Pharmacoeconomics to Improve Medical Product Selection and Use in Low- and Middle-Income Countries: Trainer’s Guide
A presentation by Kwesi Eghan, Principal Technical Advisor, on March 19, 2018.
Clear definitions and reliable measures of pharmaceutical systems strengthening (PSS) are needed to guide the design of interventions that will improve the performance and resilience of pharmaceutical systems. Despite an extensive body of work on access to and use of medicines and myriad tools that measure elements of pharmaceutical systems, there has been little attempt to conceptualize a pharmaceutical system as an entity. Based on the developed definitions of a pharmaceutical system and PSS, SIAPS developed and piloted a measurement framework and corresponding indicators to enable countries to monitor progress toward stronger, more resilient pharmaceutical systems. This document illustrates the critical system components, attributes, and outcomes that SIAPS identified for measuring PSS.
Advancing the Antimicrobial Drug Quality Agenda through Coalition Building: Lessons from AMR Response
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS. Presented at a side event during the 2018 Prince Mahidol Awards Conference on the theme “Monitoring and Improving Medicines Quality through AMR National Action Plans”, organized by USP, USAID, the Thai Food and Drug Authority, and the Thai Department of Medical Sciences on January 29, 2018 in Bangkok, Thailand.
A presentation by Francis Aboagye-Nyame, SIAPS Program Director, on March 1, 2018.
This event has been canceled and will be rescheduled to a later date.
What Gets Defined, Gets Measured: A Definition and Framework for Pharmaceutical Systems Strengthening
A presentation by Helena Walkowiak, Principal Technical Advisor for SIAPS, on December 6 2017.
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS, at USAID in Arlington, VA on November 9 2017.
Konduri N, Lebega O. Analysis of medicines expenditure in ukraine: Implications for rational selection. E9 Short oral presentation, Part 2a (Practice & Education) at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016, Buenos Aires, Argentina. August 30, 2016.
Joshi MP. Containing antimicrobial resistance to realize the goals of universal health coverage. Oral presentation at the Ecumenical Pharmaceutical Network (EPN) Forum 2016, Tubingen, Germany. May 18-21, 2016.
SIAPS worked with global and in-country partners to improve access to and use of life-saving medicines for women and children, […]
- Guidelines and Standard Operating Procedures for the Supply Chain Management of Drugs Used in Mass Drug Administration of Neglected Tropical Disease Programs
One of the constraints to effective control of neglected tropical diseases (NTDs) is that the needed medicines are often not […]
- Keep Maternal, Newborn, and Child Health Medicines Safe: Introducing MNCH commodities into a pharmacovigilance system
As countries aim to achieve the Sustainable Development Goals, there is an emphasis on increasing the availability of medicines. However, […]